Transient appearance of circulating tumor DNA associated with de novo treatment.

about

Transient appearance of circulating tumor DNA associated with de novo treatment.

Item

http://www.wikidata.org/entity/Q39116247

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Transient appearance of circulating tumor DNA associated with de novo treatment.

@en

Transient appearance of circulating tumor DNA associated with de novo treatment.

@nl

type

Item

label

Transient appearance of circulating tumor DNA associated with de novo treatment.

@en

Transient appearance of circulating tumor DNA associated with de novo treatment.

@nl

prefLabel

Transient appearance of circulating tumor DNA associated with de novo treatment.

@en

Transient appearance of circulating tumor DNA associated with de novo treatment.

@nl

P1476

Transient appearance of circulating tumor DNA associated with de novo treatment.

@en

P2093

Fumio Imamura

http://www.w3.org/2001/XMLSchema#string

Junji Uchida

http://www.w3.org/2001/XMLSchema#string

Kazumi Nishino

http://www.w3.org/2001/XMLSchema#string

Kikuya Kato

http://www.w3.org/2001/XMLSchema#string

Madoka Kimura

http://www.w3.org/2001/XMLSchema#string

Takako Inoue

http://www.w3.org/2001/XMLSchema#string

Toru Kumagai

http://www.w3.org/2001/XMLSchema#string

Yoji Kukita

http://www.w3.org/2001/XMLSchema#string

P2860

Liquid biopsies: genotyping circulating tumor DNA

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer

Rociletinib in EGFR-mutated non-small-cell lung cancer.

The Sequence Alignment/Map format and SAMtools

Fast and accurate long-read alignment with Burrows-Wheeler transform

Detection of circulating tumor DNA in early- and late-stage human malignancies

An integrated semiconductor device enabling non-optical genome sequencing

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data.

Cell-free nucleic acids as biomarkers in cancer patients.

P2888

srep38639

P304

38639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP38639

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27934896

http://www.w3.org/2001/XMLSchema#string

P932

5146655

http://www.w3.org/2001/XMLSchema#string